MedPath

Novomics Co., Ltd.

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:2
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test

Active, not recruiting
Conditions
Gastric Cancer
First Posted Date
2024-07-26
Last Posted Date
2024-07-29
Lead Sponsor
Novomics. Co., Ltd.
Target Recruit Count
237
Registration Number
NCT06521528
Locations
🇰🇷

Novomics. Co., Ltd., Seoul, Korea, Republic of

Single Patient Classifier (SPC) Prediction for Stage II and III Advanced Gastric Cancer

Completed
Conditions
Gastric Cancer
First Posted Date
2020-10-23
Last Posted Date
2024-07-22
Lead Sponsor
Novomics. Co., Ltd.
Target Recruit Count
2047
Registration Number
NCT04600518
Locations
🇰🇷

Novomics. Co., Ltd., Seoul, Korea, Republic of

Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer

Active, not recruiting
Conditions
Gastric Cancer
First Posted Date
2020-07-27
Last Posted Date
2024-12-17
Lead Sponsor
Novomics. Co., Ltd.
Target Recruit Count
581
Registration Number
NCT04487717
Locations
🇰🇷

Novomics, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.